Advisory Research’s Progyny PGNY Stock Holding History

Advisory Research’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,769	Closed	-$552K	–	338
2020 Q3	$552K	Sell	18,769 -16,110	-46%	-$444K	0.05%	229
2020 Q2	$900K	Buy	+34,879	New	+$801K	0.08%	181

Other funds holding PGNY

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Advisory Research's PGNY Position: Q4 2020 in Review

Advisory Research sold out of Progyny (PGNY) in Q4 2020, closing a stake of 18,769 shares — an estimated $552K sold.

Advisory Research first reported a position in PGNY in Q2 2020 and held it in 2 quarters. The position peaked at $900K in Q2 2020. 187 funds tracked by Wall St. Rank hold PGNY as of Q4 2020.

Advisory Research reported no remaining Progyny position as of Q4 2020 after selling out during the quarter.
Advisory Research sold 18,769 Progyny shares in Q4 2020, an estimated $552K.
Advisory Research first reported a position in Progyny in Q2 2020 and held it in 2 quarters.
Advisory Research's Progyny position peaked at $900K in Q2 2020.
187 funds tracked by Wall St. Rank held Progyny as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.